AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bcl-2 antisense oligodeoxynucleotide chemosensitizes breast carcinoma cells.

Women's Health Weekly

| September 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 SEP 2 - (NewsRx.com & NewsRx.net) -- Bcl-2 antisense oligodeoxynucleotide chemosensitizes breast carcinoma cells.

According to recent research published in the journal Breast, "this study was designed to observe whether the rates of apoptosis induced in the breast cancer cell line MCF-7 by 5-fluorouracil (5-FU) could be enhanced by transfecting bcl-2 antisense oligonucleotide (ASODN). In our experiment, bcl-2 ASODNs and control ODNs, including untreated control, sense ODN, and scrambled ODN, were transfected into MCF-7 cells."

"Changes in expression of the bcl-2 gene were examined by Western blot; cell growths were detected by MTT assay, and apoptosis rates were detected by flow cytometry (FCM). Expression of bcl-2 protein after transfection of bcl-2 ASODN was significantly lower than control ODNs. Moreover, incubation of MCF-7 with bcl-2 ASODN prior to 5-FU treatment caused remarkable loss of viable cells compared with all other control ODNs (p

"FCM showed the apoptosis rates for ASODN, untreated control, sense ODN and scrambled ODN (29.8[+ or -]7.4)%, (8.0[+ or -]2.3)%, (15.0[+ or -]5.1)% and (16.5[+ or -]7.1)%, respectively. Compared with control ODNs, ...

Related articles from newspapers, magazines, journals, and more
Antisense oligodeoxynucleotide to p21(Waf1/Cip1) suppresses tumor growth.(Brief...
Magazine article from: Women's Health Weekly February 13, 2003 700+ words
...breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett, 2003...Health. This article was prepared by Women's Health Weekly editors from staff and other reports.
Antisense oligodeoxynucleotide modulates dopamine receptors in rats.
Newspaper article from: Gene Therapy Weekly February 13, 2003 700+ words
...dopaminergic transmissions, the effects of antisense oligodeoxynucleotide (aODN) to mRNA of NR1 subunit of...methyl-D-aspartate-R1 receptor antisense oligodeoxynucleotide modulates pre- and postsynaptic expression...
Antisense oligodeoxynucleotide to p21(Waf1/Cip1) suppresses tumor growth.
Newspaper article from: Gene Therapy Weekly February 13, 2003 700+ words
...published their study in Cancer Letters (Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett, 2003;189(1):39-48). For additional information, contact...
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA...
Newspaper article from: AIDS Weekly Lisziewicz, J. Sun, D. Weichold, F.F. Thierry, A.R. Lusso, P. Tang, J.Y. Gallo, Robert C. Agrawal, S. October 3, 1994 700+ words
...of Sciences of the United States of America, "Gene-expression modulator 91 (GEM91) is a 25-nt antisense oligodeoxynucleotide phosphorothioate complementary to the Gag mRNA of human immunodeficiency virus type 1 (HIV-1). Cellular...
Pharmacokinetics of an anti-human immunodeficiency virus antisense...
Newspaper article from: AIDS Weekly Zhang, R.W. Yan, J.M. Shahinian, H. Amin, G. Lu, Z.H. Liu, T.P. Saag, M.S. Jiang, Z.W. Temsamani, J. Martin, R.R. Schechter, P.J. Agrawal, S. Diasio, R.B. September 11, 1995 700+ words
...of an article published in Clinical Pharmacology & Therapeutics, "Human pharmacokinetics of an antisense oligodeoxynucleotide phosphorothioate (GEM 91) developed as an anti-human immunodeficiency virus (HIV) agent was carried...
Double blind, placebo controlled trial of the remission inducing and steroid...
Magazine article from: Gut Yacyshyn, B.R. Chey, W.Y. Goff, J. Salzberg, B. Baerg, R. Buchman, A.L. Tami, J. Yu, R. Gibiansky, E. Shanahan, W.R. July 1, 2002 700+ words
Background and aims: To evaluate the safety and efficacy of the intercellular adhesion molecule 1 (ICAM-1) antisense phosphorothioate oligonucleotide alicaforsen (ISIS 2302) in Crohn's disease. Methods: Active (CROHN'S disease activity index (CDAI) 200-350), steroid dependent (prednisone 10-40 mg)
Charter Hospital Closings May Signal Bigger Problems Ahead, Reports Mental...
Press release article from: PR Newswire February 14, 2000 700+ words
...reports this week's issue of Mental Health Weekly. The stark numbers include 33 hospital...Karen Keiser-Jenkins told Mental Health Weekly last week. Keiser-Jenkins says the...Newswire. For more information on Mental Health Weekly, click on "Newsletters" to receive...
Problems With Managed Mental Health Program Hold Lesson For Other States,...
Press release article from: PR Newswire February 15, 1999 700+ words
...contract in state history, this week's issue of Mental Health Weekly reports. Earlier this month, the Montana legislature...Magellan. Center executive director Paul Meyer told Mental Health Weekly that in the last six months, Magellan has denied $500...
News You Can Use.(Rachel's Environmental and Health Weekly, periodical)(Brief...
Magazine article from: E Franz, Damon January 1, 2000 700+ words
...weekly publication of the Environmental Research Foundation (ERF). Much like its namesake, Rachel's Environment and Health Weekly sounds the warning about hazardous substances and technologies that threaten human and that environmental health. Rachel...
Children's treatment providers seek to bring down barriers. (includes related...
Newspaper article from: The Brown University Child and Adolescent Behavior Letter May 1, 1996 700+ words
...senior vice president of residential services at Las Vegas, NV-based Community Psychiatric Centers. Reprinted from Mental Health Weekly, Apr. 29, 1996, a sister publication of The Brown University Child and Adolescent Behavior Letter. RELATED ARTICLE...
For more facts and information, see all results

Source: HighBeam Research, Bcl-2 antisense oligodeoxynucleotide chemosensitizes breast carcinoma...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA